Retraction of: "Aldosterone receptor antagonists decrease mortality and cardiovascular hospitalizations in chronic heart failure with reduced left ventricular ejection fraction, but not in chronic heart failure with preserved left ventricular ejection fraction: a meta-analysis of randomized controlled trials"
- PMID: 37712219
- DOI: 10.23736/S2724-5683.23.06418-9
Retraction of: "Aldosterone receptor antagonists decrease mortality and cardiovascular hospitalizations in chronic heart failure with reduced left ventricular ejection fraction, but not in chronic heart failure with preserved left ventricular ejection fraction: a meta-analysis of randomized controlled trials"
Abstract
The paper entitled "Aldosterone receptor antagonists decrease mortality and cardiovascular hospitalizations in chronic heart failure with reduced left ventricular ejection fraction, but not in chronic heart failure with preserved left ventricular ejection fraction: a meta-analysis of randomized controlled trials" by Renato De Vecchis et al., which was published in Minerva Cardioangiologica 2017 August;65(4):427-42, has been retracted by the Publisher due to self-plagiarism.
Retraction of
-
Aldosterone receptor antagonists decrease mortality and cardiovascular hospitalizations in chronic heart failure with reduced left ventricular ejection fraction, but not in chronic heart failure with preserved left ventricular ejection fraction: a meta-analysis of randomized controlled trials.Minerva Cardioangiol. 2017 Aug;65(4):427-442. doi: 10.23736/S0026-4725.16.04293-6. Epub 2016 Dec 13. Minerva Cardioangiol. 2017. Retraction in: Minerva Cardiol Angiol. 2023 Oct;71(5):608. doi: 10.23736/S2724-5683.23.06418-9. PMID: 27958695 Retracted. Review.
Similar articles
-
Retraction of: "Sacubitril/valsartan improves left ventricular longitudinal deformation in heart failure patients with reduced ejection fraction".Minerva Cardiol Angiol. 2023 Oct;71(5):609. doi: 10.23736/S2724-5683.23.06419-0. Minerva Cardiol Angiol. 2023. PMID: 37712220
-
Aldosterone receptor antagonists decrease mortality and cardiovascular hospitalizations in chronic heart failure with reduced left ventricular ejection fraction, but not in chronic heart failure with preserved left ventricular ejection fraction: a meta-analysis of randomized controlled trials.Minerva Cardioangiol. 2017 Aug;65(4):427-442. doi: 10.23736/S0026-4725.16.04293-6. Epub 2016 Dec 13. Minerva Cardioangiol. 2017. Retraction in: Minerva Cardiol Angiol. 2023 Oct;71(5):608. doi: 10.23736/S2724-5683.23.06418-9. PMID: 27958695 Retracted. Review.
-
Retraction of: "Differential effects of the phosphodiesterase inhibition in chronic heart failure depending on the echocardiographic phenotype (HFREF or HFpEF): a meta-analysis".Minerva Cardiol Angiol. 2023 Oct;71(5):608. doi: 10.23736/S2724-5683.23.06421-9. Minerva Cardiol Angiol. 2023. PMID: 37712218
-
Retraction of: "Antihypertensive effect of sacubitril/valsartan: a meta-analysis".Minerva Cardiol Angiol. 2023 Oct;71(5):609. doi: 10.23736/S2724-5683.23.06420-7. Minerva Cardiol Angiol. 2023. PMID: 37712221
-
[Specific Features of Pharmacotherapy of Patients With Chronic Heart Failure and Preserved Left Ventricular Ejection Fraction].Kardiologiia. 2018 Mar;(3):84-93. Kardiologiia. 2018. PMID: 29782275 Review. Russian.
Cited by
-
Update of Takotsubo cardiomyopathy: Present experience and outlook for the future.Int J Cardiol Heart Vasc. 2022 Mar 7;39:100990. doi: 10.1016/j.ijcha.2022.100990. eCollection 2022 Apr. Int J Cardiol Heart Vasc. 2022. PMID: 35281752 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources